Exhibit 99.1


News Release                                         Contact:
                                                     Investor Inquiries
                                                     Gregory C. Thompson
                                                     440-329-6111

                                                     Media Inquiries
                                                     Lara L. Mahoney
                                                     440-329-6393


INVACARE CORPORATION RESPONDS TO UNCERTAINTY RESULTING FROM OXYGEN REPORT BY THE
OFFICE OF INSPECTOR GENERAL

     ELYRIA,  Ohio  (September  25, 2006) - On September 14, 2006, the Office of
Inspector  General  (OIG) issued a report  regarding  Medicare  spending on home
oxygen equipment, which has resulted in substantial confusion among home medical
equipment (HME) providers.

     The two objectives of the OIG report were to (1) compare Medicare  spending
for oxygen  concentrators  with the  supplier's  average  purchase price and (2)
determine the nature and frequency of servicing for  concentrators  and portable
equipment. Through its findings, the OIG report supports capping oxygen payments
at 13 months  instead of the  current 36 months.  However,  the OIG report  only
looks at the cost of oxygen concentrators, even though equipment represents only
28%  percent of the  providers'  costs of  providing  home oxygen  therapy.  The
Morrison  Informatics  study,  which has been widely circulated on Capitol Hill,
effectively  explains that over 70 percent of a provider's costs are not related
to the  equipment  acquisition,  but to  servicing  the  patient.  This is a key
message that is being explained to as many members of Congress as possible.

     The Morrison  Informatics  study is based upon more than  600,000  Medicare
beneficiaries,  while the OIG report looks at only 150  Medicare  beneficiaries.
Importantly,  the OIG report  acknowledges that it addresses neither the cost of
providing   services  nor  such  ancillary   expenses  as  billing,   processing
physician's orders,  regulatory compliance and equipment maintenance outside the
home.  The OIG also  states that  "because  Medicare  does not  require  uniform
documentation of oxygen services provided, there is no efficient way for the OIG
to accurately  measure  these  services."  As a result,  the OIG has  completely
ignored  the  services,  completely  undermining  any  conclusions  about  costs
providers incur.

     Since the  issuance of the  report,  there has been  substantial  confusion
among  HME  providers  regarding  how long  Medicare  will make  monthly  rental
payments for home oxygen therapy.  At this point,  Invacare  Corporation  (NYSE:
IVC)  believes  the current  Congress  will not reduce the existing cap below 36
months.  Should  reimbursement rules change in the future, these revisions would
not be effective on a  retroactive  basis.  Moreover,  existing  patients  would
likely be grandfathered under the current system.

     The  Company's  prediction  at this time is that the most likely  change in
Medicare  payment for home oxygen will be the Centers for  Medicare and Medicaid
Services'  (CMS) plan to change  payment for home oxygen to a modality  specific
reimbursement  system.  This may  happen as early as  January  2007.  Under CMS'
proposed  rule,  Invacare's  HomeFill  Oxygen  System will be  reimbursed at the
highest level. This implies that CMS wishes to encourage providers to make newer
technology available to patients.

     Further,  while the OIG report is by all accounts  seriously flawed in many
respects, it did state that portable oxygen is currently under-reimbursed.  This
opens the door to discussions with policy makers about increasing  reimbursement
for portable oxygen therapy (i.e., HomeFill).


     Invacare  Corporation  (NYSE: IVC),  headquartered in Elyria,  Ohio, is the
global  leader  in the  manufacture  and  distribution  of  innovative  home and
long-term care medical products that promote recovery and active lifestyles. The
company has 6,100 associates and markets its products in 80 countries around the
world. For more information about the company and its products, visit Invacare's
website at www.invacare.com.

                                       ###